Elderly multiple myeloma patients experience less deterioration in health-related quality of life than younger patients compared to a normative population: a study from the population-based PROFILES registry
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Elderly multiple myeloma patients experience less deterioration in health-related quality of life than younger patients compared to a normative population: a study from the population-based PROFILES registry
Authors
Keywords
Multiple myeloma, Quality of life, Elderly, Population based
Journal
ANNALS OF HEMATOLOGY
Volume 94, Issue 4, Pages 651-661
Publisher
Springer Nature
Online
2014-12-04
DOI
10.1007/s00277-014-2264-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evaluation of the Feasibility and Efficacy of Autologous Stem Cell Transplantation in Elderly Patients with Multiple Myeloma
- (2014) Tsuyoshi Muta et al. INTERNAL MEDICINE
- Validation of the Freiburg Comorbidity Index in 466 Multiple Myeloma Patients and Combination With the International Staging System Are Highly Predictive for Outcome
- (2013) Martina Kleber et al. Clinical Lymphoma Myeloma & Leukemia
- Personal Financial Effects of Multiple Myeloma and Its Treatment
- (2012) Julia A. Goodwin et al. CANCER NURSING
- Health-related quality of life in elderly, newly diagnosed multiple myeloma patients treated with VMP vs. MP: results from the VISTA trial
- (2012) Michel Delforge et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Health-related quality of life and disease-specific complaints among multiple myeloma patients up to 10 yr after diagnosis: results from a population-based study using the PROFILES registry
- (2012) Floortje Mols et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Lenalidomide, melphalan, and prednisone, followed by lenalidomide maintenance, improves health-related quality of life in newly diagnosed multiple myeloma patients aged 65 years or older: results of a randomized phase III trial
- (2012) M. A. Dimopoulos et al. HAEMATOLOGICA
- Continuous Lenalidomide Treatment for Newly Diagnosed Multiple Myeloma
- (2012) Antonio Palumbo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of thalidomide with melphalan and prednisone on health-related quality of life (HRQoL) in elderly patients with newly diagnosed multiple myeloma: a prospective analysis in a randomized trial
- (2011) Silvia G. R. Verelst et al. ANNALS OF HEMATOLOGY
- Thalidomide for previously untreated elderly patients with multiple myeloma: meta-analysis of 1685 individual patient data from 6 randomized clinical trials
- (2011) P. M. Fayers et al. BLOOD
- The Patient Reported Outcomes Following Initial treatment and Long term Evaluation of Survivorship registry: Scope, rationale and design of an infrastructure for the study of physical and psychosocial outcomes in cancer survivorship cohorts
- (2011) Lonneke V. van de Poll-Franse et al. EUROPEAN JOURNAL OF CANCER
- Socio-economic implications of cancer survivorship: Results from the PROFILES registry
- (2011) Floortje Mols et al. EUROPEAN JOURNAL OF CANCER
- Comorbidity as a prognostic variable in multiple myeloma: comparative evaluation of common comorbidity scores and use of a novel MM–comorbidity score
- (2011) M Kleber et al. Blood Cancer Journal
- Normative data for the EORTC QLQ-C30 and EORTC-sexuality items in the general Dutch population
- (2010) Lonneke V. van de Poll-Franse et al. EUROPEAN JOURNAL OF CANCER
- Phase III Study of the Value of Thalidomide Added to Melphalan Plus Prednisone in Elderly Patients With Newly Diagnosed Multiple Myeloma: The HOVON 49 Study
- (2010) Pierre Wijermans et al. JOURNAL OF CLINICAL ONCOLOGY
- Bortezomib Plus Melphalan and Prednisone Compared With Melphalan and Prednisone in Previously Untreated Multiple Myeloma: Updated Follow-Up and Impact of Subsequent Therapy in the Phase III VISTA Trial
- (2010) Maria-Victoria Mateos et al. JOURNAL OF CLINICAL ONCOLOGY
- Evidence-Based Guidelines for Determination of Sample Size and Interpretation of the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30
- (2010) Kim Cocks et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy of Melphalan and Prednisone Plus Thalidomide in Patients Older Than 75 Years With Newly Diagnosed Multiple Myeloma: IFM 01/01 Trial
- (2009) Cyrille Hulin et al. JOURNAL OF CLINICAL ONCOLOGY
- Bortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple Myeloma
- (2008) Jesús F. San Miguel et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started